Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
67,7 EUR | 0,00% | +0,15% | +99,12% |
11/04 | Raad van bestuur MorphoSys steunt overnamebod van Novartis nu biedperiode begint | MT |
11/04 | Directie Morphosys beveelt aanvaarding overnamebod Novartis aan | DP |
Vakgebied
Aantal werknemers: 524
Verkoop per activiteit
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Innovative Cancer Medicines
100,0
%
| 278 | 100,0 % | 238 | 100,0 % | -14,37% |
Verkoop per regio
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
88,8
%
| 0 | 0,0 % | 211 | 88,8 % | - |
Europe (excluding Germany)
11,2
%
| - | - | 27 | 11,2 % | - |
Asia
0,0
%
| - | - | 0 | 0,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jean-Paul Kress
CEO | Chief Executive Officer | 59 | 01-09-19 |
Lucinda Crabtree
DFI | Director of Finance/CFO | 45 | 07-08-23 |
Luisa Ciccarelli
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-21 |
Tim Demuth
CTO | Chief Tech/Sci/R&D Officer | 50 | 01-10-22 |
Julia Neugebauer
IRC | Investor Relations Contact | - | 01-09-06 |
Daniel Palmacci
PRN | Corporate Officer/Principal | - | 01-07-20 |
Ann Merchant
PRN | Corporate Officer/Principal | 59 | 01-01-18 |
Ralf Ostendorp
PRN | Corporate Officer/Principal | - | 01-01-99 |
Corporate Officer/Principal | - | 01-05-94 | |
Klaus de Wall
AUD | Comptroller/Controller/Auditor | - | 01-06-05 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Brosnan
BRD | Director/Board Member | 69 | 17-05-18 |
Director/Board Member | 67 | 17-05-18 | |
Marc Cluzel
CHM | Chairman | 69 | 31-05-12 |
Andrew Cheng
BRD | Director/Board Member | 57 | 18-05-22 |
Krisja Vermeylen
BRD | Director/Board Member | 62 | 01-01-17 |
Sharon Curran
BRD | Director/Board Member | 56 | 22-05-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 37 716 423 | 35 888 977 ( 95,15 %) | 53 685 ( 0,1423 %) | 95,15 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+99,12% | 2,71 mld. | |
-1,82% | 41,36 mld. | |
+44,25% | 41,3 mld. | |
+2,56% | 39,61 mld. | |
-12,11% | 25,62 mld. | |
+3,09% | 24,09 mld. | |
-24,16% | 18,38 mld. | |
+22,12% | 11,85 mld. | |
-3,74% | 11,82 mld. | |
+7,75% | 11,07 mld. |